Furthermore, retinoids including retinoid acid receptor (RAR) and retinoid X receptor (RXR) agonists were reported to decrease FOXM1 expression in human oral squamous cell carcinoma [21] and were anticipated to down-regulate its downstream KIF4 expression and, ultimately, HBV entry into human hepatocytes. Here, KIF4A is linked to oral cavity squamous cell carcinoma.